CD36 and cancer: Treatment of these cells with sulfo-N-succinyl oleate (SSO), an inhibitor of CD36 fatty acid translocase, reduced the number of lipid droplets in cancer cells, suggesting that the increase of lipid droplets following incubation with fatty acids may have been due to the direct uptake of fatty acids (Figure 5G).